Cybin Inc. Presents CYB003 Preclinical Data at Neuroscience 2022
15.11.2022 - Cybin Inc. (NEO:CYBN) (NYSE American: CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics, today announced that the Company presented a poster highlighting preclinical data for its deuterated ... Seite 1
Source: wallstreet-online.de